Live Status Check

NCT05698212 Recruiting Status

Real-time enrollment status for this endometriosis clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 7:37 AM UTC

NCT05698212 Status Summary

NCT NumberNCT05698212
Recruiting StatusRecruiting
ConditionEndometriosis
PhaseClinical Trial
Target Enrollment75 participants
Active Locations3 sites in the US
SponsorHera Biotech, Inc.
Last Updated on CT.govJanuary 26, 2023 (Jan 26, 2023)

About NCT05698212 Enrollment Status

As of July 13, 2026: Clinical trial NCT05698212 is currently recruiting participants. This clinical trial study for endometriosis is actively seeking new participants at 3 locations across the United States. The study is sponsored by Hera Biotech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT05698212

Is NCT05698212 still recruiting?

Yes, NCT05698212 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT05698212 recruiting?

This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT05698212?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT05698212 status last updated?

The official ClinicalTrials.gov record for NCT05698212 was last updated Jan 26, 2023 (January 26, 2023). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial